![These highlights do not include all the information needed to use ARANESP safely and effectively. See full prescribing information for ARANESP . ARANESP ® (darbepoetin alfa ) i njection, for intravenous or These highlights do not include all the information needed to use ARANESP safely and effectively. See full prescribing information for ARANESP . ARANESP ® (darbepoetin alfa ) i njection, for intravenous or](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=aranesp-1f.jpg&id=424531)
These highlights do not include all the information needed to use ARANESP safely and effectively. See full prescribing information for ARANESP . ARANESP ® (darbepoetin alfa ) i njection, for intravenous or
![Amgen's capabilities for the biosimilars market after establishing the... | Download Scientific Diagram Amgen's capabilities for the biosimilars market after establishing the... | Download Scientific Diagram](https://www.researchgate.net/profile/J-L-Martinez-Hurtado/publication/258954793/figure/fig3/AS:601708019322900@1520469779654/Amgens-capabilities-for-the-biosimilars-market-after-establishing-the-strategic-deals.png)
Amgen's capabilities for the biosimilars market after establishing the... | Download Scientific Diagram
![Aranesp 150 mcg sol. iniett. uso sottocutaneo 1 penna preriempita (vetro) (SureClick) 0,3 ml (500 mcg/ml) Aranesp 150 mcg sol. iniett. uso sottocutaneo 1 penna preriempita (vetro) (SureClick) 0,3 ml (500 mcg/ml)](https://www.dica33.it/cm/img/edra.png)